Maurizio Bonacini

6.9k total citations
72 papers, 3.0k citations indexed

About

Maurizio Bonacini is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Maurizio Bonacini has authored 72 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 46 papers in Hepatology and 18 papers in Infectious Diseases. Recurrent topics in Maurizio Bonacini's work include Hepatitis C virus research (41 papers), Liver Disease Diagnosis and Treatment (28 papers) and Hepatitis B Virus Studies (19 papers). Maurizio Bonacini is often cited by papers focused on Hepatitis C virus research (41 papers), Liver Disease Diagnosis and Treatment (28 papers) and Hepatitis B Virus Studies (19 papers). Maurizio Bonacini collaborates with scholars based in United States, Canada and France. Maurizio Bonacini's co-authors include Karen L. Lindsay, Massimo Puoti, Sugantha Govindarajan, Natalie Bzowej, Stan G. Louie, Amy Rock Wohl, Paul H. Hayashi, Robert J. Fontana, Hsiang Ju Lin and F. Blaine Hollinger and has published in prestigious journals such as Gastroenterology, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Maurizio Bonacini

72 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maurizio Bonacini United States 30 2.1k 1.9k 649 427 368 72 3.0k
Miguel Bruguera Spain 27 2.1k 1.0× 2.2k 1.2× 220 0.3× 486 1.1× 656 1.8× 109 3.6k
Jean‐Pierre Vinel France 30 1.7k 0.8× 2.9k 1.5× 756 1.2× 142 0.3× 960 2.6× 66 3.9k
David Mutimer United Kingdom 38 4.7k 2.2× 4.8k 2.5× 845 1.3× 224 0.5× 660 1.8× 153 5.8k
Marina Núñez Spain 33 2.3k 1.1× 2.3k 1.2× 1.5k 2.3× 206 0.5× 143 0.4× 104 3.4k
David Wong Canada 30 3.8k 1.8× 3.7k 1.9× 569 0.9× 116 0.3× 220 0.6× 126 5.6k
Giorgio Barbarini Italy 31 1.4k 0.7× 963 0.5× 762 1.2× 85 0.2× 343 0.9× 88 2.5k
Hartwig Klinker Germany 31 1.6k 0.8× 1.3k 0.7× 1.1k 1.7× 106 0.2× 99 0.3× 157 2.9k
Christopher Koh United States 31 2.2k 1.0× 1.8k 1.0× 224 0.3× 126 0.3× 367 1.0× 138 3.3k
Jaw‐Ching Wu Taiwan 38 3.0k 1.5× 3.3k 1.8× 570 0.9× 360 0.8× 549 1.5× 145 4.9k
Tse–Ling Fong United States 33 2.1k 1.0× 2.4k 1.3× 205 0.3× 175 0.4× 773 2.1× 88 3.5k

Countries citing papers authored by Maurizio Bonacini

Since Specialization
Citations

This map shows the geographic impact of Maurizio Bonacini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurizio Bonacini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurizio Bonacini more than expected).

Fields of papers citing papers by Maurizio Bonacini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurizio Bonacini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurizio Bonacini. The network helps show where Maurizio Bonacini may publish in the future.

Co-authorship network of co-authors of Maurizio Bonacini

This figure shows the co-authorship network connecting the top 25 collaborators of Maurizio Bonacini. A scholar is included among the top collaborators of Maurizio Bonacini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurizio Bonacini. Maurizio Bonacini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bonacini, Maurizio, et al.. (2017). Features of Patients With Severe Hepatitis Due to Mushroom Poisoning and Factors Associated With Outcome. Clinical Gastroenterology and Hepatology. 15(5). 776–779. 25 indexed citations
3.
4.
Manns, Michael P., Marc Bourlière, Yves Benhamou, et al.. (2010). Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection. Journal of Hepatology. 54(6). 1114–1122. 89 indexed citations
5.
Adams, Atoya, Robert G. Gish, Adil E. Wakil, et al.. (2007). Mycophenolate Mofetil in Autoimmune Hepatitis Patients Not Responsive or Intolerant to Standard Immunosuppressive Therapy. Clinical Gastroenterology and Hepatology. 5(7). 799–802. 65 indexed citations
6.
Peters, Marion G., Adrian M. Di Bisceglie, Kris V. Kowdley, et al.. (2007). Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States. Hepatology. 46(3). 769–775. 50 indexed citations
7.
Chamie, Gabriel, Maurizio Bonacini, David R. Bangsberg, et al.. (2007). Factors Associated with Seronegative Chronic Hepatitis C Virus Infection in HIV Infection. Clinical Infectious Diseases. 44(4). 577–583. 50 indexed citations
8.
Verma, Sumita, Maurizio Bonacini, Sugantha Govindarajan, et al.. (2006). More Advanced Hepatic Fibrosis in Hispanics with Chronic Hepatitis C Infection: Role of Patient Demographics, Hepatic Necroinflammation, and Steatosis. The American Journal of Gastroenterology. 101(8). 1817–1823. 53 indexed citations
9.
Bonacini, Maurizio, et al.. (2006). Pathogenesis of hepatitis C virus infection.. PubMed. 52(2). 107–23. 1 indexed citations
10.
Bonacini, Maurizio, Stan G. Louie, Natalie Bzowej, & Amy Rock Wohl. (2004). Survival in patients with HIV infection and viral hepatitis B or C. AIDS. 18(15). 2039–2045. 202 indexed citations
11.
Yu, Mimi C., et al.. (2004). Hepatitis C in a Los Ageles public hepatitis clinic: demographic and biochemical differences associated with race-ethnicity. Clinical Gastroenterology and Hepatology. 2(6). 459–462. 35 indexed citations
12.
Bräu, Norbert, M. Rodríguez‐Torres, Maurizio Bonacini, et al.. (2004). Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon α-2b+ full-course vs. 16-week delayed ribavirin. Hepatology. 39(4). 989–998. 62 indexed citations
13.
Bonacini, Maurizio. (2001). Medical management of benign oesophageal disease in patients with human immunodeficiency virus infection. Digestive and Liver Disease. 33(3). 294–300. 8 indexed citations
14.
Bonacini, Maurizio, et al.. (1999). Prevalence of Enteric Pathogens in HIV-Related Diarrhea in the Midwest. AIDS Patient Care and STDs. 13(3). 179–184. 7 indexed citations
15.
Bonacini, Maurizio, Sugantha Govindarajan, Lawrence M. Blatt, et al.. (1999). Patients co‐infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. Journal of Viral Hepatitis. 6(3). 203–208. 101 indexed citations
16.
Bonacini, Maurizio, Dajun Qian, Sugantha Govindarajan, & Boontar Valinluck. (1998). Prevalence of Hepatitis G Virus RNA in the Sera of Patients With HIV Infection. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 19(1). 40–43. 13 indexed citations
17.
Bonacini, Maurizio, Gary C. Kanel, & M. A. El Alamy. (1996). Duodenal and hepatic toxoplasmosis in a patient with HIV infection: review of the literature.. PubMed. 91(9). 1838–40. 12 indexed citations
18.
Castro, Fernando de, et al.. (1991). Myxedema Ascites Report of Two Cases and Review of the Literature. Journal of Clinical Gastroenterology. 13(4). 411–414. 23 indexed citations
19.
Bonacini, Maurizio. (1991). Pancreatic Involvement in Human Immunodeficiency Virus Infection. Journal of Clinical Gastroenterology. 13(1). 58–64. 32 indexed citations
20.
Bonacini, Maurizio, et al.. (1990). Gastrointestinal, Hepatic, and Pancreatic Involvement with Cryptococcus neoformans in AIDS. Journal of Clinical Gastroenterology. 12(3). 295–297. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel Bruguera Breakdown of academic impact, for papers by Jean‐Pierre Vinel Breakdown of academic impact, for papers by David Mutimer Breakdown of academic impact, for papers by Marina Núñez Breakdown of academic impact, for papers by David Wong Breakdown of academic impact, for papers by Giorgio Barbarini Breakdown of academic impact, for papers by Hartwig Klinker Breakdown of academic impact, for papers by Christopher Koh Breakdown of academic impact, for papers by Jaw‐Ching Wu Breakdown of academic impact, for papers by Tse–Ling Fong
Rankless by CCL
2026